Category:
Description:
Indications:
Contraindications:
Precautions:
-
Pregnancy
category C
-
CHF,
renal insufficiency, states of edema with sodium retention
-
Diminished
renal function
Adverse
Reactions (Side Effects):
-
fever,
infection at the site of injection, venous thrombosis or phlebitis
-
extravasation,
hypervolemia
|
Dosage:
Administered
intravenously
-
Dose
is dependent upon the age, weight and clinical condition of the
patient as well as laboratory determinations.
-
0.45%
Sodium Chloride Injection, USP, contains 4.5 g/L sodium chloride with an osmolarity of 154 mOsmol/L. It contains 77 mEq/L sodium and 77 mEq/L chloride
-
0.9%
Sodium Chloride Injection, USP, contains 9 g/L sodium chloride with an osmolarity of 308 mOsmol/L. It contains 154 mEq/L sodium and 154 mEq/L chloride
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks.
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Brookside Associates, LLC
All rights reserved
|
